Trial register facet
Phase 2 trial records — page 4
92 records at phase 2.
Showing 0 records on this page
Records
92 documents · page 4 of 4
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| GHKCU-TOPICAL-2 | GHK-Cu | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2007 | Low |
| PRAM-OBESITY-PH2 | Pramlintide | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | 411 | 2007 | Low |
| PRAM-OBESITY-PH2-OLEprogramme record | Pramlintide | Phase 2 | Reported | Single-arm open-label | — | 2007 | Very low |
| PRAM-OBESITY-PH2-ELDERLYprogramme record | Pramlintide | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2007 | Very low |
| PRAM-OBESITY-PH2-BIOMARKERprogramme record | Pramlintide | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2007 | Very low |
| PRAM-OBESITY-PH2-ADHERENCEprogramme record | Pramlintide | Phase 2 | Reported | Observational | — | 2007 | Very low |
| GHKCU-TOPICAL-1 | GHK-Cu | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2005 | Low |
| TA1-VACCINE-ELDERLY | Thymosin alpha-1 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1998 | Moderate |
| TA1-VACCINE-ELDERLY-BODY-COMPprogramme record | Thymosin alpha-1 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1998 | Very low |
| TA1-VACCINE-ELDERLY-QOLprogramme record | Thymosin alpha-1 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1998 | Very low |
| HEX-PH2-ELDERLY | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Low |
| HEX-PH2-ELDERLY-QOLprogramme record | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| HEX-PH2-ELDERLY-BODY-COMPprogramme record | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| HEX-PH2-ELDERLY-ELDERLYprogramme record | Hexarelin | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 1997 | Very low |
| PETRE-PH2-OBESITY | Petrelintide | Phase 2 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Not rated |
| BPC-PH2-UC | BPC-157 | Phase 2 | No retrievable report | Randomised, double-blind, placebo-controlled | — | — | Not rated |
| PETRE-PH2-OBESITY-BODY-COMPprogramme record | Petrelintide | Phase 2 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| BPC-PH2-UC-BODY-COMPprogramme record | BPC-157 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
| PETRE-PH2-OBESITY-QOLprogramme record | Petrelintide | Phase 2 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| BPC-PH2-UC-QOLprogramme record | BPC-157 | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | — | Very low |
page 4 of 4